335533
Substance use disorder (SUD) treatment outcomes among Assembly Bill 109 (AB 109) Post-Release Supervised Persons (PSPs) in Los Angeles County (LAC)
Methods:Los Angeles County Participant Reporting System treatment outcome data, Treatment, Court, Probation eXchange data, and probation recidivism data were utilized to identify SUD treatment outcomes.
Results:Since inception of AB 109 (October 1, 2011), there have been a total of 10,414 SUD treatment referrals, 5,898 SUD treatment admissions, and 4,796 discharges. Of those 4,796 discharges, 48% were discharged with positive compliance and 44% were discharged with negative compliance. PSPs who were positively compliant with SUD treatment were significantly less likely to be arrested for a new charge of a misdemeanor or felony (44%) than PSPs who were negative compliant with SUD treatment(58%). Following SUD treatment, PSPs had a significant increase in school enrollment (31%), job training (83%), and employment (35%); a significant decrease in homelessness, hospitalizations (38%), emergency room visits (36%), and physical health problems (30%). The percent increase or decrease were much greater among those who were discharged with positive compliance.
Conclusions: Substance use disorders have a serious impact on life functioning and health and are major drivers of healthcare costs. These positive treatment outcomes show how SUD treatment can positively impact on life functioning, health outcomes and health care costs.
Learning Areas:
Chronic disease management and preventionConduct evaluation related to programs, research, and other areas of practice
Epidemiology
Public health or related research
Learning Objectives:
Explain the critical component of California's Public Safety Realignment.
Describe substance use disorder treatment outcomes among Post-Release Supervised Persons (PSPs) in Los Angeles County.
Keyword(s): Drug Abuse Treatment, Criminal Justice
Qualified on the content I am responsible for because: I have been involved in research on substance use disorder treatment and outcomes for almost 3 and 1/2 years and am currently responsible for conducting research on AB 109 population.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.